CEO Executive AssistantDelegation for insurance policy pricing authority is one of the most consequential and technically complex authority transfers an insurance CEO makes. Pricing decisions drive underwriting profitability, competitive position, regulatory compliance, and actuarial adequacy simultaneously. Get the delegation structure right and your chief pricing officer and product managers move with the speed the market requires while your loss ratios and regulatory standing remain sound. Get it wrong and you find out about pricing problems in quarterly results, regulatory correspondence, or actuarial reviews rather than in time to correct course.
This article provides a practical framework for how insurance CEOs structure pricing authority: who approves what, at what thresholds, under what governance conditions, and where the CEO’s direct involvement is genuinely required.
Why Pricing Authority Is Different from Other Insurance Delegations
Pricing authority in insurance is structurally different from most other executive authority delegations because of the regulatory dimension. In most industries, a CEO can delegate pricing authority and the principal governance questions are commercial and financial. In insurance, pricing decisions also implicate state regulatory filings, actuarial sign-off requirements, rate adequacy standards, and in some lines, prior approval processes where regulators must approve rates before they take effect.
This regulatory overlay does not mean the CEO should retain pricing authority centrally. It means the delegation structure must be built with regulatory compliance as a non-negotiable constraint. Your chief pricing officer (CPO) and product managers need authority to make pricing decisions quickly to remain competitive. Your regulatory affairs and actuarial functions need to be integrated into the process to ensure those decisions are compliant and actuarially defensible.
A second distinction: pricing decisions in insurance are probabilistic. A rate change that looks correct with current data may prove inadequate as claims develop over a multi-year period. The governance structure you build must account for this lag: you cannot evaluate pricing quality from quarter-to-quarter results alone. Build in actuarial adequacy review as a governance layer, not just commercial performance.
Forbes has noted that insurance pricing innovation is accelerating as data and technology capabilities expand. The organizations that move fastest do so with delegated pricing authority that is governed well, not with centralized approval that slows every rate action.
Structuring the Chief Pricing Officer’s Authority
Your chief pricing officer (or equivalent: head of pricing, chief actuary with pricing responsibility, or pricing director depending on your organization’s structure) should have broad operational pricing authority within defined parameters. The CPO is the right decision owner for pricing within your filed rate structures: the rates, factors, and algorithms that operate within approved regulatory filings.
Within-filing pricing authority means the CPO can adjust rates, factors, and underwriting guidelines within the bounds of your approved state filings without a separate approval process. This is core operational authority. Product managers and underwriting teams operate within the filed structure. The CPO oversees compliance with filed rules and monitors pricing results.
The CPO’s authority at this level should be comprehensive: adjustment of rating factors within filed ranges, modification of underwriting guidelines within filed parameters, pricing model refinement and recalibration, competitive response within filed rates, and approval of individual account pricing exceptions within defined deviation limits.
Filing authority is a separate and more consequential level. Rate filings (submitting revised rates to state regulators) require actuarial certification, legal review, and in prior-approval states, regulatory approval before implementation. Your CPO should have authority to initiate, develop, and submit rate filings with actuarial and regulatory affairs coordination. For filings within a defined range of rate change (for example, plus or minus 10 to 15 percent in any single state), the CPO has authority to submit after actuarial sign-off. For larger rate changes or filings that represent material strategic shifts in pricing position, require CEO review and approval before submission.
This threshold protects you from large pricing moves that have regulatory, competitive, or actuarial implications that warrant executive attention, while allowing the CPO to move quickly on routine rate maintenance and competitive adjustments.
Product Manager Pricing Authority
Product managers (by line of business, distribution channel, or customer segment) should have operational pricing authority within the structure the CPO has established. This is the level where competitive pricing decisions get made day-to-day.
Define product manager authority along two dimensions: individual account deviation authority and segment pricing adjustment authority.
Individual account deviation authority allows a product manager to approve pricing that deviates from standard rates for a specific account or risk. Define this as a percentage deviation from filed rates (for example, up to 15 percent deviation from filed rates for personal lines, up to 25 percent for commercial lines where individual account underwriting is more common). Deviations above the product manager’s limit require CPO approval. Document all deviations in your pricing system so you can monitor deviation volume and magnitude over time.
Segment pricing adjustment authority is broader: the ability to apply systematic pricing changes to a defined book segment without individual account review. Product managers in most insurance organizations should not have this authority independently. Systematic segment adjustments have loss ratio implications that require actuarial review and CPO approval. Define this as a CPO-level decision, with product managers proposing and supporting the analysis.
Pricing exceptions (accounts where standard pricing rules are waived for strategic or relationship reasons) deserve specific treatment. These create adverse selection risk if not managed carefully. Require that all pricing exceptions above a defined deviation from filed rates be documented with a specific business rationale, approved by the CPO, and reviewed quarterly for loss ratio performance against the exception cohort. If exception accounts are performing materially worse than standard book, that is a signal requiring CPO attention and potentially policy changes.
Rate Approval Thresholds and Escalation
Your rate approval threshold structure is the core mechanism that ensures appropriate executive visibility into material pricing decisions while allowing routine decisions to proceed without bottlenecks.
A practical threshold structure for insurance pricing authority:
CPO approves without CEO review: Rate filings representing changes of less than plus or minus 10 percent in any single state; underwriting guideline changes within filed parameters; pricing model recalibrations that maintain current overall rate level; competitive response pricing within filed structures; individual account deviations within defined percentage limits.
CEO review required before submission or implementation: Rate filings representing changes of more than plus or minus 10 to 15 percent in any single state; rate actions in states that represent more than 10 percent of your premium volume; pricing changes that affect your competitive position in a material market segment; any pricing action prompted by regulatory inquiry or examination finding; pricing changes for products or segments being introduced or discontinued.
Board notification appropriate: Rate actions representing more than a defined percentage of total company premium (for example, 5 percent of total in-force premium affected); rate changes that your actuarial team identifies as required to maintain rate adequacy but that carry material competitive risk; state-specific regulatory actions that require rate rollbacks or refunds.
Build a 48-hour turnaround commitment into your CEO review process for pricing decisions that require your approval. Your CPO should not be waiting two weeks for a rate filing decision. If you cannot turn rate approval decisions quickly, the delegation structure breaks down and your team will route decisions around you rather than through you.
Competitive Pricing Governance
Competitive pricing in insurance requires speed. Your competitors are moving rates, adjusting underwriting appetites, and changing distribution incentives continuously. A pricing governance process that requires extensive internal approvals for competitive responses will systematically underperform.
Give your CPO authority to make competitive response pricing decisions within filed structures without CEO approval. The CPO should receive regular competitive intelligence: rate surveys, competitor rate filings (public in most states), distribution channel feedback on win/loss patterns, and broker market intelligence. Based on this intelligence, the CPO directs competitive pricing responses within the authority structure you have defined.
Competitive pricing thresholds should be defined in terms of what competitive response actions remain within the CPO’s authority versus require CEO input. A structured way to think about this: competitive responses that keep your pricing within 5 percent of market median on key segments are CPO-level decisions. Competitive responses that require you to price below your actuarially indicated adequate rate (to match a competitor who may be underpricing) require CEO discussion. You are the right decision owner for the question of whether to accept inadequate pricing for competitive reasons.
Establish a quarterly competitive pricing review with your CPO, actuarial, and commercial leadership. Review your pricing position by segment against market benchmarks, your win/loss rates at different price points, and your loss ratio by segment against industry comparators. This review keeps you informed about competitive pricing dynamics without requiring you to be in every decision.
Insurance pricing authority structures follow the same threshold-based logic as authority in other domains. The regulatory and actuarial dimensions add complexity, but the fundamental principle holds: define what requires your judgment, delegate the rest clearly.
Actuarial Adequacy as a Governance Guardrail
Actuarial sign-off is the discipline that protects your pricing delegation from producing rate inadequacy. Define explicitly how the actuarial function integrates with pricing authority.
For all rate filings, require actuarial certification of rate adequacy before filing submission. This is standard regulatory practice in most jurisdictions, but make it an internal governance requirement independent of regulatory mandates. Your CPO cannot submit a rate filing without actuarial sign-off. This is not optional.
For within-filing pricing changes (adjustments that do not require new state filings), establish a process for periodic actuarial review of aggregate pricing adequacy. Your chief actuary or pricing actuary should review your total book’s rate adequacy quarterly and report the finding to you and the CPO. If adequacy is deteriorating, the CPO and actuarial team develop a rate action plan and bring it to you with a defined timeline.
Adverse development triggers are worth defining in your governance structure. If reported loss ratios in a given period exceed your pricing target by a defined threshold (for example, 5 or more loss ratio points against target for two consecutive quarters), require a formal pricing adequacy review that includes both actuarial and CPO participation, with findings and proposed corrective action presented to you within 30 days.
Filing Authority and Regulatory Interface
Regulatory affairs for rate filings is a specialized function that intersects with your pricing authority structure. Define who manages regulatory relationships during the filing process and who has authority to respond to regulatory inquiries about your rates.
Your regulatory affairs team (or external counsel, depending on your organization’s size) should manage the filing submission and tracking process. The CPO owns the actuarial and technical content of filings. When regulators raise questions about filed rates, the regulatory affairs team and CPO jointly respond, with legal review for substantive positions.
For regulatory examinations that focus on pricing practices, rating factor application, or underwriting guidelines, escalate to CEO immediately. Regulatory examinations carry enforcement risk that requires executive awareness regardless of the examination’s scope.
Admitted versus non-admitted lines may require different governance structures. Non-admitted (surplus lines) business typically operates with more pricing flexibility because it is not subject to state rate filing requirements. Give your surplus lines product managers and underwriters more operational pricing flexibility in non-admitted lines, while maintaining actuarial adequacy review as a governance requirement.
Regulatory compliance governance in pricing requires that your delegation structure be documented and defensible to regulators if examined. Keep a clear written record of your pricing authority matrix, the individuals who hold each level of authority, and any changes to the structure over time.
Conclusion
Delegation for insurance policy pricing authority requires a framework that balances competitive speed with actuarial discipline and regulatory compliance. Your chief pricing officer should hold broad operational authority within filed structures and filing authority for routine rate changes. Product managers operate within the CPO’s established parameters. You stay in the decision for material rate changes, competitive strategy inflection points, regulatory matters, and pricing actions that carry adequacy risk.
The governance structure that works is threshold-based, documented, and integrated with actuarial review and regulatory affairs. It gives your pricing team the authority to act quickly on the competitive intelligence they develop, while preserving the executive oversight that rate adequacy and regulatory standing require. Insurance pricing is too consequential and too technical to manage by committee: build clear authority, hold leaders accountable for results, and stay informed through governance rather than transaction.